In A Nutshell Staying consistently active throughout adulthood can cut all-cause death risk by up to 40%, especially for ...

Baird analyst Colin Sebastian joins the GeekWire Podcast to discuss Amazon, Google, and Meta’s AI strategies, tech investing ...

WHAT THIS STUDY ADDS This systematic review and meta-analysis confirms modest efficacy of infliximab for pulmonary sarcoidosis and highlights promising but limited evidence for adalimumab, tofacitinib ...

Infliximab and efzofitimod may be effective in pulmonary sarcoidosis and tofacitinib and adalimumab in cutaneous sarcoidosis.

Social support interventions designed to combat depression and improve quality of life among older adults show limited effectiveness, according to a comprehensive systematic review and meta-analysis ...

Doing a certain amount of exercise is linked to a 30% to 40% lower risk of an early death from any cause, according to a new ...

The National Cancer Institute and University of Oxford report that oral contraceptive use is not associated with increased ...

A meta-analysis of 187 trials shows that Paxlovid and remdesivir reduce the risk for hospitalization in patients with mild-to ...

The risk for severe RSV-related outcomes was effectively reduced among children and infants who received nirsevimab in real-world clinical settings.

Meta Platforms Inc.'s hiring spree for top-tier artificial-intelligence talent has one analyst questioning the company's approach to competing in the AI race and wondering whether the moves bring near ...

Background Evidence on preventing Alzheimer’s disease (AD) is challenging to interpret due to varying study designs with heterogeneous endpoints and credibility. We completed a systematic review and ...